Insights on Digital GxP Documentation

The revised EU Annex 11 introduces enhanced requirements for exit strategies, ensuring pharmaceutical companies maintain control over their critical GMP data.

ISPE's framework for organizations to confidently move away from paper-based systems while maintaining regulatory compliance.

The revised EU Chapter 4 explicitly incorporates ALCOA++ principles as the foundation for data integrity in pharmaceutical manufacturing.